DMD and Becker muscular dystrophy: Recent in vitro studies on Duchenne and Becker muscular dystrophy and in vivo studies in mdx mice have demonstrated that inhibitors of the proteasome pathway can effectively block the degradation of dystrophin and dystrophin-associated proteins and improve the morphology of dystrophin-deficient skeletal muscle [19], [27], [30].